Vincerx Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Vincerx Pharma's estimated annual revenue is currently $5.6M per year.
- Vincerx Pharma's estimated revenue per employee is $201,000
Employee Data
- Vincerx Pharma has 28 Employees.
- Vincerx Pharma grew their employee count by -36% last year.
Vincerx Pharma's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Biometrics | Reveal Email/Phone |
2 | Head medicinal chemistry | Reveal Email/Phone |
3 | Head Target Discovery, non-clinical Biology, Pharmakology & DMPK | Reveal Email/Phone |
4 | SVP Clinical Development | Reveal Email/Phone |
5 | Senior Director Chemical Development | Reveal Email/Phone |
6 | Sr. Director Medical Safety Systems | Reveal Email/Phone |
7 | Senior Director, Head Statistical Programming | Reveal Email/Phone |
8 | Associate Director Clinical Operations | Reveal Email/Phone |
9 | Director Clinical Programming and Data Science | Reveal Email/Phone |
10 | Senior Director, Informatics Support & QMS Infrastructure | Reveal Email/Phone |
Vincerx Pharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $102.7M | 511 | 25% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $38.6M | 192 | 3% | N/A | N/A |
#4 | $35M | 127 | 2% | $62.5M | N/A |
#5 | $36.6M | 182 | 18% | N/A | N/A |
#6 | $131.9M | 656 | -3% | N/A | N/A |
#7 | $133.5M | 664 | N/A | N/A | N/A |
#8 | $72.8M | 362 | -4% | N/A | N/A |
#9 | $551.9M | 1716 | -2% | N/A | N/A |
#10 | $11.7M | 58 | 12% | N/A | N/A |
What Is Vincerx Pharma?
Vincerx is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer.
keywords:N/AN/A
Total Funding
28
Number of Employees
$5.6M
Revenue (est)
-36%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vincerx Pharma News
2022-04-06 - Vincerx Pharma Highlights VIP152 Preclinical, Clinical Data In
Gynecological Cancers - Benzinga
Vincerx Pharma Highlights VIP152 Preclinical, Clinical Data In Gynecological Cancers ... [TODAY ONLY] Get 50% OFF and get 2 bear market-beating...
2022-04-06 - Vincerx Pharma Presents Preclinical and Preliminary Clinical ...
Vincerx Pharma Presents Preclinical and Preliminary Clinical Data on PTEFb/CDK9 Inhibitor VIP152 in Gynecologic Malignancies at the American...
2022-03-30 - Vincerx Pharma Reports Fourth Quarter and Full Year 2021 ...
About Vincerx Pharma, Inc. Vincerx Pharma, Inc. (Vincerx) is a clinical-stage life sciences company focused on leveraging its extensive...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.5M | 28 | 33% | $13M |
#2 | $3.2M | 28 | 75% | N/A |
#3 | $1.7M | 28 | 4% | N/A |
#4 | $7M | 28 | 0% | N/A |
#5 | $2.8M | 28 | 8% | N/A |